×
First-in-class phase 2a study of anb020 (anti-il-33) in the treatment of moderate-to-severe atopic dermatitis
Chen Y., Gutowska-Owsiak D., Westmoreland M., Mackenzie T., Cifuentes L., Lloyd-Lavery A., Marquette A., Kenney B., Londei M., Ogg G.
Type
Conference paper
Publication Date
2018-01-01T00:00:00+00:00
Volume
73
Pages
77 - 77
Total pages
0